VBI Vaccines Inc. (VBIVQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 30, 2024, 9:59 AM EDT
VBI Vaccines Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 9.41 | 8.68 | 1.08 | 0.63 | 1.06 | 2.22 | Upgrade
|
Revenue Growth (YoY) | 553.09% | 702.40% | 71.47% | -40.53% | -52.23% | -33.80% | Upgrade
|
Cost of Revenue | 11.67 | 12.51 | 11.28 | 10.77 | 9.17 | 7.9 | Upgrade
|
Gross Profit | -2.26 | -3.83 | -10.19 | -10.14 | -8.11 | -5.68 | Upgrade
|
Selling, General & Admin | 36.53 | 42.14 | 56.12 | 38.34 | 20.65 | 14.09 | Upgrade
|
Research & Development | 8.76 | 9.34 | 15.51 | 19.56 | 14.86 | 26.33 | Upgrade
|
Operating Expenses | 45.29 | 51.49 | 71.63 | 57.89 | 35.51 | 40.42 | Upgrade
|
Operating Income | -47.55 | -55.31 | -81.82 | -68.03 | -43.62 | -46.11 | Upgrade
|
Interest Expense | -8.15 | -8.06 | -5.22 | -5.1 | -3.32 | -3.03 | Upgrade
|
Interest & Investment Income | 1.36 | 1.66 | 1.39 | 0.37 | 0.61 | 0.84 | Upgrade
|
Currency Exchange Gain (Loss) | -4.04 | -6.52 | -27.48 | 3.01 | 0.1 | -0.22 | Upgrade
|
EBT Excluding Unusual Items | -58.39 | -68.24 | -113.13 | -69.75 | -46.23 | -48.52 | Upgrade
|
Impairment of Goodwill | -1 | -1 | - | - | - | -6.29 | Upgrade
|
Asset Writedown | -1 | -1 | - | - | - | - | Upgrade
|
Other Unusual Items | - | - | -0.17 | - | - | - | Upgrade
|
Pretax Income | -82.99 | -92.84 | -113.3 | -69.75 | -46.23 | -54.81 | Upgrade
|
Net Income | -82.99 | -92.84 | -113.3 | -69.75 | -46.23 | -54.81 | Upgrade
|
Preferred Dividends & Other Adjustments | 1.01 | 1.01 | - | - | - | - | Upgrade
|
Net Income to Common | -83.99 | -93.84 | -113.3 | -69.75 | -46.23 | -54.81 | Upgrade
|
Shares Outstanding (Basic) | 20 | 16 | 9 | 8 | 7 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 20 | 16 | 9 | 8 | 7 | 4 | Upgrade
|
Shares Change (YoY) | 127.29% | 80.90% | 1.30% | 16.80% | 82.73% | 81.95% | Upgrade
|
EPS (Basic) | -4.29 | -6.03 | -13.16 | -8.21 | -6.35 | -13.77 | Upgrade
|
EPS (Diluted) | -4.30 | -6.03 | -13.16 | -8.21 | -6.35 | -13.77 | Upgrade
|
Free Cash Flow | -51.48 | -61.75 | -78.04 | -41.9 | -48.05 | -52.39 | Upgrade
|
Free Cash Flow Per Share | -2.63 | -3.97 | -9.07 | -4.93 | -6.60 | -13.16 | Upgrade
|
Gross Margin | -24.02% | -44.06% | - | - | - | -255.88% | Upgrade
|
Operating Margin | -505.30% | -637.08% | -7561.92% | -10781.62% | -4110.93% | -2075.96% | Upgrade
|
Profit Margin | -892.47% | -1080.87% | -10471.63% | -11054.36% | -4357.21% | -2467.94% | Upgrade
|
Free Cash Flow Margin | -547.03% | -711.24% | -7212.48% | -6640.73% | -4528.75% | -2358.62% | Upgrade
|
EBITDA | -45.58 | -53.32 | -79.76 | -66.2 | -41.97 | -44.9 | Upgrade
|
D&A For EBITDA | 1.98 | 1.99 | 2.06 | 1.84 | 1.65 | 1.2 | Upgrade
|
EBIT | -47.55 | -55.31 | -81.82 | -68.03 | -43.62 | -46.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.